Hospital Authority’s Post

🌍 World Transplant Day: Spotlight on Pediatric Kidney Transplantation🌍 In recognition of World Transplant Day on June 6th, let's address some frequently asked questions about kidney transplantation in children. Increased awareness can empower families and enhance support for our young patients. Q1: Why is kidney transplantation necessary in children? A1:Kidney transplantation becomes essential for children with end-stage renal disease (ESRD), where the kidneys are no longer able to perform their vital functions. A transplant can greatly enhance their quality of life and long-term health. Q2: How do children get on the transplant list? A2:Following a thorough medical evaluation by a pediatric nephrologist and transplant team, children with ESRD are added to the transplant list. This evaluation includes their medical history, physical exams, and various tests to confirm their suitability for transplantation. Q3: What are the sources of donor kidneys for children? A3: Donor kidneys for children come from living donors, often family members, or deceased donors. Living donor transplants usually have better outcomes due to shorter waiting times and lower rejection rates. Q4: What are the risks associated with kidney transplantation in children? A4: Kidney transplantation, like any major surgery, carries risks such as infection, rejection of the donor kidney, and complications from immunosuppressive medications. Nevertheless, with vigilant care and monitoring, many of these risks can be effectively managed. Q5: How does life change for a child after a kidney transplant?  A5: After a kidney transplant, children typically experience improved energy levels, growth, and overall health. However, they will need lifelong follow-up care, including regular check-ups, medication adherence, and lifestyle adjustments to keep the transplanted kidney healthy. Q6: What support systems are available for families? A6: Families can access various support systems, including counselling, support groups, and educational resources. These support networks are crucial for managing the emotional and psychological aspects of the transplantation journey. By spreading knowledge about these important aspects, we can better support children undergoing kidney transplantation and advocate for the critical need for organ donation. Let's make a positive impact this World Transplant Day! 🌟💙👧👦 #WorldTransplantDay #PediatricNephrology #KidneyTransplantation #ChildrensHealth #OrganDonation #TransplantAwareness

It's #NationalNursesWeek! For children battling cancer, nurses play a central role in their day-to-day treatment. They are the managers of their care — whether it’s the critical hours around surgery or days at the oncology clinic. Here are five stories from nurses who are making a difference for children with cancer: https://lnkd.in/eUairbb6

In 2021, 1,146 pediatric heart transplant candidates awaited transplantation, with over 40 percent enduring waits of a year or more. Particularly concerning are outcomes for infants under 1 year old, with 23 percent succumbing to end-stage heart failure while on the waitlist. Children are our future #pediatrics

#DidYouKnow? Millions of people require blood transfusions every year due to surgery, serious injury or illnesses like leukemia or kidney disease. In this explainer from Advent Health, learn about the different types of blood donations and the unique impact of each. #NationalBloodDonorMonth

Elevating Transplant Recovery Excellence with TRP Welcome to Transplant Recovery Pros (TRP), where we’re reshaping the transplant recovery process into an art form of efficiency and precision. Our suite of comprehensive services is the beacon of innovation in the transplant recovery arena. Round-the-Clock Expert Support: Our team of professionals is available 24/7, bringing unparalleled expertise to every phase of the transplant recovery journey. Their dedication ensures a consistently high standard of care and operational excellence. State-of-the-Art Transportation Logistics: Speed and safety are the twin pillars of our advanced logistics system. We understand the critical nature of time in transplant recovery, and our logistics are fine-tuned to ensure rapid, secure transportation of organs and tissues. Pioneering Recovery Preservationists: Our experienced recovery preservationists leverage the latest in medical technology, ensuring each organ’s viability and integrity. Their skilled hands are crucial in maintaining the highest success rates in transplant recoveries. Innovative Collaboration with MEDIGO: In our stride toward technological advancement, we’ve partnered with MEDIGO to harness the capabilities of the MediGO RECOVERY TEAMLINK™ system. This integration fosters unmatched coordination and efficiency in our operations. Tailored Recovery Supplies and Solutions: Recognizing the uniqueness of each transplant scenario, we provide customized recovery supplies and perfusion solutions. This bespoke approach ensures that each transplant is supported with the precise resources it requires. Champions of Organ and Tissue Research: Our commitment extends beyond recovery processes. We actively support organ and tissue research, contributing to the broader medical community through our certified staff’s procurement efforts. Anticipating Growth in Demand: The rising demand for our services, coupled with favorable market trends, speaks volumes about our impact and reliability. We’re constantly evolving, aiming to set new benchmarks in the transplant recovery sector. Join us at Transplant Recovery Pros. Together, we’re not just participating in the transplant recovery process; we’re redefining it. TRP stands as your committed ally in every step of this life-saving journey. Let’s continue to make transplant recovery more efficient, effective, and extraordinary.

Dear All, Really excited about this paper - along with coauthors Antonio Cabrera Kurt Schumacher Bibhuti Das David Peng Wendy Zhang and Robert Gajarski - our analysis of the pre and post transplant critical care therapies used and their impact on Pediatric Heart Transplantation was just published in #JHLT Journal of Heart and Lung Transplantation. Although we do hundreds of pediatric heart transplants every year - we know very little about the critical care needs pre and post transplantation, especially in our contemporary cohort. This analysis of over 1800 patients across majority of the centers in North America provides extensive insights in to this knowledge gap. Impact of CHD , single ventricle, smaller patients post palliation and VAD / ECMO patients have all unique needs pre and post Transplantation. The study highlights some of these key needs. 1. A major finding is the fact that now, CHD is the dominant indication for Transplantation in children of all ages. 2. Biventricular surgically palliated children waiting for transplant are actually sicker than the overall cohort of the single V patients with significantly higher critical care needs 3. For the first time, impact of surgical variables on the outcome is recognized in a large scale study The study identifies some key risk factors and raises some hypothesis questions for us. Work will continue. Eager to know your thoughts. Thank you and take care, Shri #pediatriccare #hearttransplantation #singleventricle #congenitalheartdisease #outcomes #criticalcare #JHLT Anuradha (Anu) Lala-Trindade (Lala)Rob MentzDaniel Goldstein, MDBiykem BozkurtGil Wernovsky MD

📃Scientific paper: Exploring the Performance of Ultrasound Risk Stratification Systems in Thyroid Nodules of Pediatric Patients Abstract: SIMPLE SUMMARY: Although pediatric thyroid nodules are uncommon, they need high clinical expertise and alert since they carry a greater risk of malignancy compared with those presenting in adults. Since there are no specific ultrasound (US)-based risk stratification systems (RSSs) for pediatric thyroid nodules, the application of adult-based RSSs in the pediatric population could represent a step forward in the care of children and adolescents with thyroid nodules. We compared the diagnostic performance of the main US-based RSSs *i.e., the American College of Radiology (ACR), European (EU), Korean (K) Thyroid Imaging Reporting and Data Systems (TI-RADSs) and ATA US RSS criteria) for detecting malignant thyroid lesions in pediatric patients. For ACR TI-RADS and EU-TIRADS, we found a sensitivity of 41.7%, and, for K-TIRADS and ATA US RSS, we found a sensitivity of 50%. The four US-based RSSs (i.e., ACR-TIRADS, EU-TIRADS, K-TIRADS, and ATA US RSS) have suboptimal performance in managing pediatric patients with thyroid nodules, with one-half of cancers without indication for FNA according to their recommendations. All thyroidologists, as well as the panelists of next TIRADSs, should be aware of these findings. ABSTRACT: Neck ultrasound (nUS) is the cornerstone of clinical management of thyroid nodules in pediatric patients, as well as adults. The current study was carried out to explore and compare the diagnostic performance of the main US-based risk stratification syste... Discover the rest of the scientific article on es/iode ➡️https://etcse.fr/Lgp

"Brain tumours are the second most common type of childhood cancer. Prognosis tends to vary across the different paediatric age groups, based on the type and the site of the lesion.... Compared to children with other solid tumours and haematological malignancies, children with brain tumours receiving palliative care often tend to progress slowly and present with a very high symptom burden during the course of their illness progression" To continue reading: https://lnkd.in/gCr7iBkQ Jayita Deodhar Shamali P. Dr. Shreya Nair Manasi Patil Dr Prajakta Bhagat To subscribe to the IAPC's free monthly e newsletter: https://lnkd.in/gmf5Z7KK #palliativecare #compassionatecare #ComfortCare #QualityOfLife #SeriousIllness #PainManagement #patientCare #Caregivers #SupportiveCare #PalliativeMedicine #DignityInCare #Dignity #endoflifecare #oncology #oncologypalliativecare #neuropalliativecare #Neurology

               Asia’s First heart transplant without blood transfusion  It gives me immense pleasure to announce a ground-breaking achievement at Marengo Asia Hospitals, by utilizing the most innovative techniques in Asia for the first time to do a “ Heart Transplant without blood transfusion “  This medical breakthrough will revolutionize the organ transplant surgeries not just in India, but throughout the entire Asian region . Asia’s first case involving the bloodless technique was operated at our Ahmedabad hospital (Marengo CIMS hospital)  on a 52-year-old patient from India who was diagnosed with Ischemic Dilated Cardiomyopathy and was in the advanced stage of heart failure. Significantly, the individual who underwent this protocol therapy was discharged from the hospital on 9th day, a stark deviation from the usual 21 to 24 days of hospitalization required for conventional heart transplant patients. The heart transplant team was lead by Dr Dhiren Shah , ably supported by Dr Dhaval Naik. The anesthesia   team was led Dr Niren Bhavsar .   The reduction of the length of stay will help patients save both direct and indirect costs making such complex procedures more affordable specially for families who travel from other cities where the cost of logistics is unnecessary additional burden on them. This achievement positions Marengo Asia Hospitals among the top 5 global institutes and first in Asia in performing absolute Zero blood transfusion in highly complex heart transplant procedures. A blood transfusion-free heart transplant represents a remarkable milestone in cardiac transplant surgery, highlighting the significant strides made in surgical techniques and technology. We are establishing a Hemostasis Center of Excellence . This is in line with our endeavor to develop clinical Centre of excellence ( COE)  by  embracing new technology   which aims to enhance the patient experience and clinical outcomes  .                              " Every life matter’s every minute counts" #heathcare#marengoasiahealthcare#marengoasiahospitals#MarengoCIMS#Werfen#healthinnovations#patientfirst#hearttransplant#organdonation

📍 Small pump for kids awaiting heart transplant shows promise in Stanford Medicine-led trial A new type of surgically #implanted #pump that can support a child’s failing heart has passed the first stage of human testing in a Stanford Medicine-led trial. Stanford Medicine researchers and their colleagues have found that an implantable ventricular assist device, shown here, allows children with heart failure to live relatively normal lives while they await a transplant. Courtesy of Jarvik Heart, Inc. A small, implantable cardiac pump that could help children await heart transplants at home, not in the hospital, has performed well in the first stage of human testing. The pump, a new type of ventricular assist device, or VAD, is surgically attached to the heart to augment its blood-pumping action in individuals with heart failure, allowing time to find a donor heart. The new pump could close an important gap in heart transplant care for children. In a feasibility trial of seven children who received the new pump to support their failing hearts, six ultimately underwent heart transplants and one child’s heart recovered, rendering a transplant unnecessary. The results were published May 7 in the Journal of Heart and Lung Transplantation. The study was led by the Stanford School of Medicine and included several medical centers in the United States. If the early results are confirmed in a larger trial of the device, waiting for a heart transplant could become easier for small children and their families. The new pump, called the #Jarvik2015 ventricular assist device, is slightly larger than an AA battery and can be implanted in children weighing as little as 18 pounds. With the pump implanted, kids can take part in many normal activities while they wait for a heart transplant. Read ➡️ https://lnkd.in/eZKWyxkA #feasibilitytrial #clinicaltrial #device #childrenshealth